Neurocrine Biosciences, Inc. (NBIX) Stock Price, News, Quote & History

By Yahoo! Finance | Aug 28, 2024 at 12:31 PM EST

Neurocrine Biosciences disappoints investors with Phase 2 data on schizophrenia treatment. The study showed an 18.2-point reduction in symptoms with NBI-1117568 compared to 10.8 points with placebo, as regulators assess Bristol Myers' treatment.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.